Does Health Insurance Improve Health? Evidence From Massachusetts

It is always important to remember that healthcare and health insurance are two very different things, and neither of them is a guarantee of good health.
Published Online: February 21, 2014

It is always important to remember that healthcare and health insurance are two very different things, and neither of them is a guarantee of good health. Therefore, when people talk about Obamacare providing people with medical care, we have to remember that it primarily provides people with health care insurance. And as I have written about previously, insurance coverage does not guarantee the receipt of quality healthcare, with many Medicaid recipients having a hard time finding doctors willing to see them.

Now comes a new study from Massachusetts, exploring whether expansion of health insurance within that state through Romneycare has improved the health of that state’s citizens. In the study, the researchers conducted a before/after look at the health of people in Massachusetts.

Read the full story here: http://onforb.es/1jQqUTz

Source: Forbes

Feature
Recommended Articles
Although the cost of oral oncolytic medications can vary greatly, cost sharing routinely plays less of a role because patients with cancer nearly always reach their maximum out-of-pocket limits, especially in late-stage disease care. Bruce A. Feinberg, DO, and Brian B. Kiss, MD, recently addressed this issue in the final segment on palliative care from the Oncology Stakeholders Summit, Spring 2015 meeting.
Patient-reported outcomes are beginning to influence FDA approvals and coverage decision making by payers. How oral oncolytics are affecting quality of life and patient preferences was also discussed in this fifth segment of the Oncology Stakeholders Summit, Spring 2015 series, with Bruce A. Feinberg, DO, and Brian B. Kiss, MD.
Although GOP presidential hopefuls are all campaigning on promises to repeal and replace President Obama's Affordable Care Act (ACA), the last real chance to repeal may have been the 2012 election, according to Avik Roy, senior fellow at the Manhattan Institute.
Certain exchange benefit plans have recently begun to place all specialty medications for complex diseases on the highest drug formulary cost-sharing tier, according to an analysis from Avalere Health.